Conversely, other studies have found increased nesfatin-1 levels in individuals with T2DM and those with impaired glucose tolerance, revealing positive correlations with fasting blood glucose (FBG), plasma insulin, glucose levels measured two hours post-load, and HOMA-IR scores [31]. This evidence concerns the gene NUCB2 and Impaired glucose tolerance.